L'intérêt à découvert pour PROCEPT BioRobotics donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de PROCEPT BioRobotics. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

PROCEPT BioRobotics (NASDAQ:PRCT) Stock, Rapport sur les intérêts à découvert

PROCEPT BioRobotics

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

PROCEPT BioRobotics Corporation - Common Stock

PROCEPT BioRobotics Corp

Lake Street analyst Jaeson Schmidt maintains BK Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) with a Buy and raises the price target from $40 to $51.

News

Price Target

Analyst Ratings

BKTI

Lake Street Maintains Buy on BK Technologies, Raises Price Target to $51

Motorola Solutions, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) shares are trading lower on Monday. The company introduced SVX, <a href="https://www.benzinga.com/pressreleases/25/04/b44894857/motorola-solutions-launches-svx-and-assist-converging-two-way-radio-with-body-camera-and-ai-into-o" target="_blank" rel="noreferrer noopener">a video remote speaker microphone</a>.
It combines secure voice, video, and AI capabilities, tailored for use with its flagship APX NEXT radio.
Motorola Solutions is streamlining first responder operations by combining body camera capabilities with their core communication tool — the radio.
Alongside this, the company also launched Assist, a new AI-powered tool aimed at equipping every first responder in the U.S. with advanced technology, reinforcing its mission of "Solving for safer."
The new Assist platform marks a breakthrough in human-AI collaboration for public safety.
It aims to deliver personalized, real-time insights tailored to the specific context of each situation, person, and location where critical decisions are made.
Mahesh Saptharishi, executive vice president and chief technology officer, Motorola Solutions said, &#8221;We&#8217;ve designed SVX and Assist to combine secure voice, video and AI with exceptional quality and capability for the people in uniform who protect us all.&#8221;
The company plans to release first-quarter 2025 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">earnings results on Thursday, May 1</a>.
Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Telecom ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XTL#NYSE">XTL</a>) and iShares U.S. Telecommunications ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IYZ#BATS">IYZ</a>).
Price Action: MSI shares are trading lower by 2.00% at $412.51 at last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/mid-cap/25/04/44890609/hertz-global-and-webull-stocks-are-among-top-mid-cap-gainers-last-week-apr-14-apr-18-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Hertz Global And Webull Stocks Are Among Top Mid-Cap Gainers Last Week (Apr 14-Apr 18): Are The Others In Your Portfolio?</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

Movers

iShares Dow Jones US Telecommunications Sector Index Fund

Motorola Just Launched Something That Could Change How First Responders Use AI

XRP is trading 2.96% higher to start the week at $2.10, snapping a multiday slump with signs of renewed momentum in the futures market. The token is down 2.24% over the past seven days and has lost 11.78% over the last month—but <a href="https://www.benzinga.com/money/how-to-buy-ripple-xrp#:~:text=To%20purchase%20XRP%20on%20a,your%20assets%20as%20the%20custodian.">bullish sentiment is beginning to reemerge</a>.
<h2 class="wp-block-heading">Long Bets Climb, RSI Signals Momentum Shift</h2>
Futures market data shows traders are beginning to lean long on XRP again, with the token's long/short ratio climbing to 1.07. That marks a meaningful shift in positioning, as more traders are now betting on upward price movement than on declines—a potential signal of confidence returning to the market.
Supporting the trend is XRP's relative strength index (RSI), which has risen to 50.77. The RSI measures momentum and overbought/oversold conditions, and a move above the neutral 50 level typically indicates growing demand. In this case, it suggests buying pressure is starting to outweigh selling, a necessary precursor to any meaningful breakout.
Don&#8217;t Miss: 
<ul>
<li>New to crypto? <a href="https://www.benzinga.com/go/coinbase-promo">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses </a>— no wallets, just price speculation and free paper trading to practice different strategies.</li>
</ul>
If current momentum continues, XRP could retest the key $2.18 resistance level in the coming sessions. That price marks an important technical barrier; flipping it to support may <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44894713/xrp-jumps-4-what-is-going-on">open the door for a move to $2.29</a>. If bulls fail to sustain the rally, however, XRP could drop back toward $2.03 or even $1.99.
<h2 class="wp-block-heading">Technical Compression Signals a Move Is Coming</h2>
Market watchers are also flagging an unusual technical compression on XRP's chart. According to CoinDesk, Bollinger bandwidth on XRP's 4-hour chart has narrowed to its lowest level since October 2024—a pattern that often precedes high-volatility moves. The last time this setup occurred, XRP staged a breakout rally.
Still, the "spring compression" setups can swing both ways. While a rally is possible, a downside move is also on the table, particularly with some macro uncertainty lingering. The last time bandwidth compressed this tightly was just before the FTX crash in 2022, CoinDesk noted.
Traders will be watching closely for a directional break above $2.18 or below $2.03 to confirm whether the setup resolves bullishly or bearishly.
<h2 class="wp-block-heading">Broader Market Momentum Lends Support</h2>
Bitcoin's surge above $87,000 on Monday helped boost sentiment across the crypto market. XRP, along with BNB and SOL, notched modest gains during the session as traders revisited the "digital gold" thesis amid renewed inflation fears and a weakening U.S. dollar.
Gold also hit a fresh all-time high above $3,380 per ounce. Treasury Secretary Scott Bessent downplayed concerns about a Treasury sell-off in a Bloomberg interview last Monday, but noted that the U.S. is exploring new leadership for the Federal Reserve and hinted that volatility could persist until markets fully absorb the shift in interest rate outlook.
If macro headwinds continue to ease and crypto momentum holds, XRP's bullish case may strengthen—particularly as traders pile into altcoins with high liquidity and ETF speculation tailwinds.
XRP's short-term setup is showing signs of life after a volatile month. Long positioning, RSI momentum and tight Bollinger bandwidth all point to a potential breakout—with $2.18 and $2.29 coming as the next upside targets. On the flip side, support at $2.03 and $1.99 remains key to maintaining structure if the rally falters.
With macro conditions still fluid and ETF speculation brewing in the background, XRP could be poised for a larger move—traders just need confirmation of the direction.
Read Next: 
<ul>
<li>Maximize saving for your retirement and cut down taxes: <a href="https://moneypickle.go2cloud.org/aff_c?offer_id=14&amp;aff_id=1002">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;</li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.masterworks.com/?ref=zdbimty&amp;utm_source=Benzinga&amp;utm_medium=affiliate&amp;utm_campaign=Benzinga+Newsgen">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%</a>. </li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

XRP Rally Resumes With Momentum Indicators Flashing Green

Fartcoin (CRYPTO: FARTCOIN) has emerged as the meme coin to watch, outperforming its more famous counterparts like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>). 
A wave of smart money and whale buying has helped push Fartcoin up 88% in the last month, coinciding with <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44896411/bitcoin-catapults-to-87000-what-is-going-on">Bitcoin's rally to $87,000.</a>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Fartcoin (CRYPTO: FARTCOIN)</td>
<td>&nbsp;$0.8797</td>
<td>$879.7 million</td>
<td>+7.1%&nbsp;</td>
<td>-1.2%&nbsp;</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1600</td>
<td>$23.8 billion</td>
<td>+3.7%&nbsp;</td>
<td>-2%&nbsp;</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001250</td>
<td>$7.4 billion</td>
<td>+2.2%&nbsp;</td>
<td>+2.5%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Popular crypto analyst Altcoin Sherpa <a href="https://x.com/AltcoinSherpa/status/1914095583297679780">says</a> Fartcoin is "looking pretty good." 
In an April 20 <a href="https://x.com/AltcoinSherpa/status/1913903094091620479">post</a> on X, he predicted a run to the $0.90s followed by a potential retest of $0.75 or lower. 
He views a move to $0.70 as a gift for patient traders preparing for the next structured leg higher. However, Bitcoin's rally will be the deciding factor for Fartcoin&#8217;s price trajectory.  
In another X post, Sherpa also outlined two possible paths: a continuation higher or a corrective dip, depending largely on Bitcoin's next move. He disclosed holding a "big bag" of Fartcoin himself.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fartcoin has 2 paths, it can go up or it can go down (but mostly dependent on BTC) Still long with a large bag of this for now <a href="https://t.co/uq9xkGYPbE">pic.twitter.com/uq9xkGYPbE</a>
&mdash; Altcoin Sherpa (@AltcoinSherpa) <a href="https://twitter.com/AltcoinSherpa/status/1914273803347144803?ref_src=twsrc%5Etfw">April 21, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Degengambleeth <a href="https://x.com/degengambleh/status/1914265445542019407">raised</a> the possibility of Fartcoin cracking a $1 billion market cap, citing increasing investor interest and momentum.
Statistics: Fartcoin has <a href="https://x.com/StalkHQ/status/1913729329634414692">topped</a> the charts as the most purchased token ($1.96 million) by smart money over the past 24 hours. 
A separate Stalkchain <a href="https://x.com/StalkHQ/status/1914260016573337981">update</a> on Monday has flagged a wallet aggressively dollar-cost averaging into Fartcoin, with $1 million invested in two batches: $500,000 at an average of $0.8907 and another $500,000 at $0.9128.
In addition, a wallet directly funded by crypto casino Rollbit's treasury <a href="https://x.com/StalkHQ/status/1914051248229142652">loaded</a> up with $758,000 worth of Fartcoin, signaling growing institutional curiosity in the meme coin sector.
Read Next:&nbsp;
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44846673/meme-coin-market-is-very-much-alive-can-dogecoin-shiba-inu-fartcoin-bounce-back">Meme Coin Market Is &#8216;Very Much Alive&#8217;: Can Dogecoin, Shiba Inu, Fartcoin Bounce Back?</a></li>
</ul>
Image: Shutterstock

$DOGE

$SHIB

Not Dogecoin, Shiba Inu — Here's Why Whales Are Piling Into Fartcoin

Marriott International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) has outperformed the market over the past 20 years by 2.24% on an annualized basis producing an average annual return of 10.05%. Currently, Marriott International has a market capitalization of $59.24 billion. 
Buying $1000 In MAR: If an investor had bought $1000 of MAR stock 20 years ago, it would be worth $6,529.89 today based on a price of $215.12 for MAR at the time of writing.
<h3>Marriott International's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745249412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) will report its <a href="https://www.benzinga.com/calendars/earnings?tickers=VZ">first-quarter earnings</a> on Tuesday before the market opens. Wall Street is expecting earnings per share of $1.15 and revenue of $33.24 billion, per <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0421">Benzinga Pro</a> data, as the telecom giant rings in its 2025 kickoff quarter.
The stock has increased 14.09% over the past year and has gained 9.52% year to date.
Let's examine the charts for Verizon stock and how it currently compares to Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/personal-finance/25/04/44889713/how-much-would-it-take-to-earn-100-a-month-from-verizon-stock">How Much Would It Take To Earn $100 A Month From Verizon Stock</a>
<h2 class="wp-block-heading">Verizon Stock Riding Momentum Ahead Of Q1 Earnings</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0421"><img loading="lazy" decoding="async" width="627" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21094426/Screenshot-2025-04-21-at-7.14.04-PM.png" alt="" class="wp-image-879787" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21094426/Screenshot-2025-04-21-at-7.14.04-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/21094426/Screenshot-2025-04-21-at-7.14.04-PM-300x234.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0421" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Verizon has been quietly riding the momentum wave. With shares currently trading at $44.04, the stock sits above its five, 20-, and 50-day exponential moving averages &#8211; an undeniably bullish trend. The 20-day simple moving average of $41.90 further reinforces the bullish setup.
Even longer-term indicators agree: the 50-day simple moving average is at $41.83, while the 200-day is $43.06, giving bulls reason to stay tuned. Verizon's Moving Average Convergence Divergence (MACD) at 0.77 and Relative Strength Index (RSI) of 56.12 suggest the stock still has room to run.
<h2 class="wp-block-heading">Verizon Analysts See 8% Upside</h2>
Ratings &amp; Consensus Estimates: The <a href="https://www.benzinga.com/quote/VZ/analyst-ratings">consensus analyst rating</a> on Verizon stock stands at Neutral with a price target of $45.65.
However, the three most recent ratings from Scotiabank, Oppenheimer, and RBC Capital average to a slightly more optimistic price target of $47.83 &#8211; pointing to an 8.29% potential upside from current levels.
Price Action: Verizon stock was trading at $44.75 at the time of publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44896337/teslas-q1-test-drive-will-earnings-steer-tesla-stock-out-of-the-ditch">Tesla Q1 Test Drive: Will Earnings Steer The Stock Out Of The Ditch?</a></li>
</ul>
Image: Shutterstock

Technicals

Previews

Tech

Verizon Q1 Earnings Preview: Bulls Dial In As Technicals Light Up

William Blair analyst Matt Phipps initiates coverage on Context Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTX#NASDAQ">CNTX</a>) with a Outperform rating.

Initiation

CNTX

William Blair Initiates Coverage On Context Therapeutics with Outperform Rating

William Blair analyst Matt Phipps initiates coverage on Xencor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNCR#NASDAQ">XNCR</a>) with a Outperform rating.

XNCR

William Blair Initiates Coverage On Xencor with Outperform Rating

Wedbush analyst Seth Basham maintains CarMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) with a Outperform and maintains $90 price target.

Wedbush Maintains Outperform on CarMax, Maintains $90 Price Target

Bernstein analysts on Monday identified five structural forces that could drive Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) trajectory in the coming months, based on rising institutional demand, regulatory developments and <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44499889/bitcoin-is-fulfilling-its-destiny-as-world-reserve-currency-says-bitcoin-whale-trace-mayer">new U.S. government initiatives</a>.
The findings, according to Bernstein, lay out key inflection points now anchoring Bitcoin&#8217;s position within global capital markets.
What Happened: According to the report, one of the core developments underpinning Bitcoin's market resilience is the establishment of a <a href="https://www.benzinga.com/news/25/04/44778849/peter-schiff-says-trumps-strategic-bitcoin-reserve-is-already-down-over-12-claims-if-wed-bought-gold-instead-wed-be-up-2-right-now">Strategic Bitcoin Reserve by the U.S. government</a>.
Originally funded through seized BTC assets held across federal agencies, the Bitcoin reserve move has been widely interpreted by analysts as formal recognition of Bitcoin as a sovereign-grade asset akin to digital gold.
This designation has already catalyzed renewed interest from corporate treasuries and sovereign entities.
A second catalyst highlighted is fresh institutional Bitcoin demand, particularly from corporate buyers and ETFs. 
Despite turbulence earlier this year, outflows from U.S.-listed Bitcoin ETFs have slowed, indicating a stickier base of long-term capital. 
Bernstein notes that around <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44898586/strategy-adds-555-million-in-bitcoin-ups-stash-to-538200-btc">80 corporates globally</a> now hold Bitcoin on their balance sheets.
The third driver comes from <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44894658/deutsche-bank-standard-chartered-reportedly-looking-into-expanding-to-us-crypto-market">growing momentum in the banking sector</a>.
The report outlines that major banks, wealth managers and broker-dealers are ramping up efforts to integrate crypto into traditional financial services.
This includes custodial services, tokenized treasuries and the adoption of blockchain infrastructure for payments and settlement rails.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44896411/bitcoin-catapults-to-87000-what-is-going-on">Bitcoin Catapults To $87,000: What Is Going On?</a>
Bernstein's fourth key catalyst centers on the expected passage of the Stablecoin legislation in the U.S. this year. 
The bill is likely to <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44812762/stablecoins-to-surge-to-2-trillion-by-2028-says-standard-chartered-heres-what-it-means-for-the-dollar">institutionalize stablecoin operations</a> and embed them deeper into payment systems.
Stablecoins already settle over $1 trillion in monthly volume and are increasingly seen as tools for cross-border trade and B2B payments. 
The report calls this a foundational layer for the next generation of digital finance.
The final catalyst is a renewed push by asset managers and broker-dealers to embrace tokenization. 
Tokenized U.S. Treasuries already represent a $5 billion market, with BlackRock's BUIDL fund alone accounting for $2 billion. 
Bernstein points to this trend as validation of tokenized finance as a scalable infrastructure play rather than a speculative niche.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44894658/deutsche-bank-standard-chartered-reportedly-looking-into-expanding-to-us-crypto-market">Deutsche Bank, Standard Chartered Reportedly Looking Into Expanding To US Crypto Market</a></li>
</ul>
Image: Shutterstock

$BTC

5 Catalysts That Could Drive Bitcoin Higher: Bernstein

Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) is trading 0.84% higher to $138.21 on Monday, continuing a measured uptrend after touching $142.65 in early trading. The token is up 3.55% over the past seven days and has gained 6.77% over the past month, outperforming most top-ten cryptocurrencies amid <a href="https://www.benzinga.com/money/how-to-buy-solana#:~:text=Make%20Your%20Purchase&amp;text=To%20complete%20the%20transaction%2C%20head,you%20would%20like%20to%20purchase.">a string of bullish headlines</a>.
<h2 class="wp-block-heading">Institutional Bet Signals Confidence in Solana Treasury Strategy</h2>
The latest spark for Solana's momentum came from a $100 million private investment led by crypto trading firm GSR into Upexi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPXI#NASDAQ">UPXI</a>), which announced plans to shift toward a Solana-based treasury strategy. Upexi, previously focused on consumer product distribution, said it would begin accumulating and staking Solana as part of a broader pivot to digital assets.
Don&#8217;t Miss: 
<ul>
<li>New to crypto? <a href="https://www.benzinga.com/go/coinbase-promo">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses </a>— no wallets, just price speculation and free paper trading to practice different strategies.</li>
</ul>
GSR's involvement is notable. The firm cited Solana's speed, scalability, and developer ecosystem as core reasons for backing the strategy. Upexi shares surged nearly 500% on the news
<h2 class="wp-block-heading">Solana Surpasses Ethereum in Staking Market Cap</h2>
The bullish momentum also reflects Solana's strengthening position within the staking economy. According to StakingRewards, Solana's staking market capitalization briefly overtook Ethereum's, hitting $53.15 billion compared to Ethereum's $53.72 billion. That shift is driven in part by Solana's higher staking yield—8.31% compared to Ethereum's 2.98%—and the fact that 65% of its circulating supply is currently staked.
<h2 class="wp-block-heading">Whale Moves and Price Levels to Watch</h2>
Despite mixed views on staking security, institutional interest in Solana appears to be growing. Blockchain data shows a range of high-volume whale activity over the past week, including large withdrawals from exchanges and staking-related transfers. U.S.-listed firm Janover <a href="https://in.benzinga.com/trading-ideas/movers/25/04/44822969/whats-going-on-with-janover-shares-today">increased its Solana holdings to over $21 million</a> and announced a partnership with Kraken to stake its assets.
On the technical front, SOL is facing resistance near $144, with a break above that range potentially opening the door to a retest of its March highs. Support is seen near $129—a level that held firm during recent volatility and remains a crucial floor in the event of a pullback.
<h2 class="wp-block-heading">Looking Ahead: Breakpoint, Developer Momentum, and Market Tailwinds</h2>
Solana continues to benefit from a string of network-level upgrades, including improvements to validator client diversity, progress on the QUIC data transfer protocol, and ongoing developer migration via Solang, a compiler that supports Ethereum's Solidity language.
While Solana's rise has been swift, questions remain about whether its high staking ratio could constrain DeFi liquidity—especially in comparison to Ethereum's more mature ecosystem. For now, the token's blend of strong technicals, expanding institutional adoption, and an active developer base appears to be enough to keep bulls in control.
Browse Next: 
<ul>
<li>Maximize saving for your retirement and cut down taxes: <a href="https://moneypickle.go2cloud.org/aff_c?offer_id=14&amp;aff_id=1002">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;</li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.masterworks.com/?ref=zdbimty&amp;utm_source=Benzinga&amp;utm_medium=affiliate&amp;utm_campaign=Benzinga+Newsgen">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%</a>. </li>
</ul>
Image: Shutterstock

$SOL

UPXI

Solana Pushes Higher As Staking Milestone And Institutional Bets Fuel Rally

ORCA-3 Demonstrated a Significant Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo
Cytisinicline New Drug Application (NDA) Submission to FDA Planned for June 2025
SEATTLE and VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHV#NASDAQ">ACHV</a>), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced that complete trial results from its ORCA-3 were published in the <a href="https://www.globenewswire.com/Tracker?data=AzbFrMUa4qC2IbEBD16NY2rJNGxPwdX0O0sSNUXm_aDNy28vyLWeW_-LrD35xDfNniKB7qenEIsDHhVOfNuzgqQBT5PhwPzigaGEAXCbGA0oMoKEGoLFcazCYGG_M0etUoLYv5WYKOzS0YzTCMvBN1yl8lF3OSfWZbTuyNSlDUCERj0Qbg1wwS-rkFa8zkSIjpcUbOhlVqybZdUOL5uKnKI0ps_T8Sz0eIlvT9YsuZs=">Journal of the American Medical Association (JAMA) Internal Medicine</a>. ORCA-3 was the second randomized, placebo-controlled Phase 3 clinical trial evaluating cytisinicline for smoking cessation in 792 U.S. adults. The authors concluded that ORCA-3 reaffirms cytisinicline's efficacy and tolerability for smoking cessation in adult smokers at both 6- and 12-week treatment durations, including reduction in nicotine cravings and extended cessation benefits through 24 weeks.
In addition to previously reported <a href="https://www.globenewswire.com/Tracker?data=xGGUKHvpcxeWCIC-Z8NndUDLz7kunUODptVNw36_g3bn81hVavT23ahXHl3YSWWPTZXXuEQI0szEHPNsvgJtsatTNmDU7dwGMmspJobqokCDGVER_nvCWRtOGqqzH87__skWCtumfg4fMfBW1vskjTo62km53Vx0rdLF9aXo9qoZq3un0dbhm20J-BoQWvvK-J3fmIaeO-r0ioXbCjP_qw==">topline results</a> announced in May 2023, the published completed trial results provided further evidence of cytisinicline's highly targeted effect on treating nicotine dependence by binding to specific nicotine receptors. These consistent results, now published from two large, randomized Phase 3 trials, demonstrated that cytisinicline significantly reduced nicotine cravings and increased the likelihood of quitting smoking. In clinical trials, cytisinicline was well tolerated, which is thought to be due to limited other off-target binding effects that can result in side effects known to be associated with currently available treatments.
Similar to the first Phase 3 trial, ORCA-3 participants had an average age of 53 years, smoked a median of 20 cigarettes per day at baseline, and had a median smoking history of 36 years with four prior quit attempts.

ACHV

Achieve Life Sciences Says Cytisinicline Phase 3 ORCA-3 Trial Results Showed Increase in Quitting and Reduction in Nicotine Cravings for Cytisinicline-Treated Participants Compared to Placebo

Evogene Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVGN#NASDAQ">EVGN</a>) stock rallied over 20% on Monday following the <a href="https://www.benzinga.com/topic/mergers-and-acquisitions">announcement of an acquisition</a>.
What Happened: The Israel-based company <a href="https://www.benzinga.com/pressreleases/25/04/n44893783/icl-to-acquire-the-activity-of-evogenes-subsidiary-lavie-bio" target="_blank" rel="noreferrer noopener">agreed</a> to sell a majority of Lavie Bio Ltd., its subsidiary, to ICL. 
Terms of the deal remain undisclosed.
ICL will also gain control of Evogene&#8217;s MicroBoost AI for AG platform.
This strategic acquisition strengthens ICL&#8217;s position in the ag-biologicals sector. Lavie Bio will continue its operations within ICL&#8217;s expanded structure. 
Key assets to be transferred to ICL include Lavie Bio&#8217;s core team, technology platform, microbial bank, and commercial products.
See Also: <a href="https://editorial.benzinga.com/wp-admin/post.php?post=879284&amp;action=edit">Gold Rallies To Record, Dollar Drops &#8211; Global Markets Today While US Slept</a>
Why It Matters: The transaction builds on more than two years of collaboration between ICL and Lavie Bio, focused on developing innovative bio-stimulant solutions for agriculture.
&#8220;We believe this transaction unlocks significant value for Evogene&#8217;s shareholders,&#8221; said Ofer Haviv, CEO of Evogene. &#8220;Integrating Lavie Bio into ICL will accelerate progress in the global ag-biologicals market, driving innovation in agriculture.&#8221;
Price Action: EVGN shares are trading higher by 24.74% at $1.21 premarket Monday.
At last check, it was trading higher by almost 20.5%. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/04/44896834/dollar-hits-3-year-lows-us-stocks-tumble-as-trump-threatens-to-fire-powell-contrarians-of-the-world-unite">Dollar Hits 3-Year Lows, US Stocks Tumble As Trump Threatens To Fire Powell: &#8216;Contrarians Of The World, Unite!&#8217;</a></li>
</ul>

BASFY

EVGN

THRY

Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AI

Snap-on&#xAE; announced today its diagnostic platforms have been&nbsp; approved by Mercedes-Benz USA and certified by Auto Authentication Authority (AutoAuth) to access&nbsp; Mercedes Benz vehicles' gateway modules. The ability to work with Mercedes-Benz secure systems is&nbsp; available on Snap-on Wi-Fi enabled products operating the latest software.&nbsp; Automobile manufacturers are developing solutions to protect their vehicles' networks from unauthorized&nbsp; access, including potential cyber-attacks, by securing vital systems behind gateways. Mercedes-Benz,&nbsp; along with several other manufacturers, have implemented a secure gateway module that was&nbsp; introduced on a selection of 2021 and newer model vehicles. For those vehicles with the secure gateway&nbsp; module, access to certain diagnostic functions requires registration and authentication through an&nbsp; approved device for all aftermarket scan tools

MERCEDES-BENZ UNSP / ADR by Mercedes Benz Group AG

MBGYY

Snap-on Approved For Access To Mercedes-Benz Secured Gateway Vehicles

Stifel analyst Brian Brophy maintains Titan America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTAM#NYSE">TTAM</a>) with a Buy and lowers the price target from $16 to $15.

TTAM

Stifel Maintains Buy on Titan America, Lowers Price Target to $15

Stifel analyst Jonathan Block maintains Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) with a Buy and lowers the price target from $15 to $14.

NYXH

Stifel Maintains Buy on Nyxoah, Lowers Price Target to $14

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) jumped 3.52% on Monday to $87,348.17, extending its rebound above key resistance as institutional buying and <a href="https://www.benzinga.com/money/how-to-buy-bitcoin-btc-best-bonuses-august-2024#:~:text=Users%20need%20to%20set%20up,bank%20transfers%2C%20and%20other%20cryptocurrencies.">macroeconomic tailwinds boosted sentiment across crypto markets</a>.&nbsp;
The coin is now up 3.9% over the last seven days and has gained 3.91% over the past month.
<h2 class="wp-block-heading">MicroStrategy&#8217;s $556M Purchase Cements Dominance</h2>
Bitcoin's latest leg higher coincides with a fresh round of accumulation by Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), which disclosed it added 6,556 BTC between April 14 and April 20 for a total of $555.8 million—paying an average of $84,785 per coin.
The purchase lifts MicroStrategy's total holdings to 538,200 BTC, valued at roughly $46.8 billion at current prices, and gives the company an average cost basis of $67,766 per coin. It now controls roughly 77% of the 700,000 BTC held by publicly traded firms, solidifying its role as the largest corporate holder of Bitcoin.
Don&#8217;t Miss: 
<ul>
<li>New to crypto? <a href="https://www.benzinga.com/go/coinbase-promo">Get up to $400 in rewards for successfully completing short educational courses and placing your first qualifying trade</a> on Coinbase.</li>
<li><a href="https://www.benzinga.com/go/plus-500-crypto-in-content">Trade crypto futures on Plus500 with up to $200 in bonuses </a>— no wallets, just price speculation and free paper trading to practice different strategies.</li>
</ul>
The buy was funded through two stock sale programs, with the company issuing 1.755 million shares of Class A stock and 91,000 shares of preferred stock. Net proceeds totaled $555.5 million.
<h2 class="wp-block-heading">Bitcoin Breaks Out As Dollar Weakens, Inflation Fears Resurface</h2>
BTC's move above $87,000 reflects broader shifts in global macro dynamics. The U.S. Dollar Index (DXY) dropped to a three-year low of 98.00 following reports that President Donald Trump is <a href="https://www.benzinga.com/25/04/44888232/trumps-top-economic-adviser-kevin-hassett-says-white-house-is-exploring-options-to-fire-fed-chair-jerome-powell-t">weighing the removal of Federal Reserve Chair Jerome Powell</a>. The political pressure on the Fed has driven speculation around interest rate cuts and helped fuel demand for safe-haven assets like Bitcoin and gold.
Gold surged to fresh all-time highs above $3,400 per ounce on Monday, and traders pointed to Bitcoin's renewed correlation with gold as a signal of its reemerging hedge narrative.
Crypto financial services firm Matrixport said, "a weaker dollar could draw renewed attention from American investors, highlighting bitcoin&#8217;s potential as a hedge against declining dollar value."&nbsp;&nbsp;
<h2 class="wp-block-heading">Cost-Basis Clusters Suggest $90K May Be In Play</h2>
According to Coindesk, Bitcoin could face limited overhead resistance below $90,000 due to thin supply clusters in that range. It suggests that if momentum continues, BTC could push toward new highs relatively quickly before major profit-taking sets in.
Market data also reflects increased risk appetite across crypto markets, with small-cap tokens like ENJ, MAGIC and SOL outperforming. Bitcoin's dominance currently sits near 54%, underscoring its role in leading broader market trends.
Browse Next: 
<ul>
<li>Maximize saving for your retirement and cut down taxes: <a href="https://moneypickle.go2cloud.org/aff_c?offer_id=14&amp;aff_id=1002">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li>It&#8217;s no wonder Jeff Bezos holds over $250 million in art — <a href="https://www.masterworks.com/?ref=zdbimty&amp;utm_source=Benzinga&amp;utm_medium=affiliate&amp;utm_campaign=Benzinga+Newsgen">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%</a>. </li>
</ul>
Image: Shutterstock

MSTR

Bitcoin Surges Past $87K As Strategy Expands Holdings And Dollar Weakness Fuels Hedge Appeal

Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) with a Hold and lowers the price target from $190 to $175.

INSP

Stifel Maintains Hold on Inspire Medical Systems, Lowers Price Target to $175

A few thematic and leveraged ETFs shone last week, posting solid gains as other markets retreated due to worries over geopolitics and macroeconomic uncertainty. Across the spectrum, from biotech and streaming to crypto and transportation, some funds flashed decent returns.
T-Rex 2X Long DJT Daily Target ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/DJTU#BATS">DJTU</a>) jumped 33.5%, the week&#8217;s best performer as the Dow Jones Transportation Average recovered on Thursday.
Defiance Daily Target 2X Long LLY ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLYX#NYSE">LLYX</a>) rose 22.3% as Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) shares soared 11.34%. Investors remain optimistic about the company&#8217;s blockbuster weight-loss and diabetes medications, which continue to drive revenue growth and provide robust forward guidance.
Direxion Daily NFLX Bull 2X Shares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFXL#NASDAQ">NFXL</a>) gained 8.8%, echoing the<a href="https://www.benzinga.com/general/entertainment/25/04/44877995/netflix-crushes-q1-says-its-working-hard-to-improve-and-expand-its-offering"> robust quarterly performance</a> of Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>). The streaming behemoth surpassed Wall Street expectations, with the increase in its ad-supported plan and better content performance providing bulls a reason to rejoice.
SPDR Galaxy Digital Asset Ecosystem ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DECO#NASDAQ">DECO</a>) gained 5.5% as stabilizing Bitcoin prices and increasing institutional interest in digital asset infrastructure supported it. Favorable sentiment in the overall crypto market helped support the fund&#8217;s holdings in blockchain and crypto-exposed assets.
Yieldmax MSTR Option Income Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSTY#NYSE">MSTY</a>) increased by 3%, taking advantage of MicroStrategy&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) solid performance and consistent returns earned from its options-based income strategy based on Bitcoin.
These ETF profits were impressive compared to the broader market&#8217;s losses during the last holiday-shortened week.
What Happened In The Markets Last Week
Markets were rattled by fresh geopolitical tensions and hawkish central bank commentary. The largest drag was from the technology sector, following Nvidia Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) announcement that it had been informed by the Trump administration that <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/44886016/nvidias-do-not-enter-sign-caught-in-a-category-5-tariff-storm">exports of its H20 AI chip to China </a>would need a license. The firm warned that the export controls would lower earnings by $5.5 billion, pushing its shares down 8.5%. The news also <a href="https://www.benzinga.com/25/04/44799456/chip-shock-3-hot-semiconductor-etfs-to-watch-as-trumps-tariff-bomb-ticks">affected the wider chip industry</a>, with the iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) losing 3%—its seventh loss in the last eight weeks.
Earnings were mixed. While banks and Netflix reported positive results, UnitedHealth Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) surprised markets by cutting its full-year forecast. The stock lost 22.4% in one session—the worst one-day decline for the insurer since 1998.
On the trade side, Canada temporarily paused counter measure tariffs on critical U.S. imports to relieve cross-border supply chain stress—most notably helping Midwest-based auto manufacturers.
Meanwhile, Federal Reserve Chairman Jerome Powell again expressed reluctance to cut interest rates, citing lingering inflation and risks to trade-driven growth. President Donald Trump condemned the move, calling Powell &#8220;always too late&#8221; and threatening to fire him before his term ends in May 2026. Trump spoke against a backdrop of irritation over the European Central Bank&#8217;s sixth consecutive interest rate reduction, further amplifying the divergence of monetary policies in developed nations.
Against this background of policy uncertainty and volatility, gold was the shining star. The SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>) jumped to an all-time high of $3,330 per ounce, recording gains in 14 of the last 16 weeks, as investors flocked to the yellow metal for safety.
While headwinds beset the overall market, last week&#8217;s ETF action highlights where momentum—and investor confidence—is still present.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44876466/the-10k-handbag-hoax-tiktoks-trade-war-puts-luxury-etfs-in-the-hot-seat">The $10K Handbag Hoax? TikTok&#8217;s Trade War Puts Luxury ETFs In The Hot Seat</a></li>
</ul>
Photo: Shutterstock

Broad U.S. Equity ETFs

ETFs

DECO

DJTU

LLYX

Tidal Trust II YieldMax MSTR Option Income Strategy ETF

MSTY

NFLX

NFXL

NVDA

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

ETFs Last Week: Thematic ETFs Gleamed Against Market Gloom

Stifel analyst David Grossman maintains Infosys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) with a Hold and lowers the price target from $18 to $17.

INFY

Stifel Maintains Hold on Infosys, Lowers Price Target to $17

Press Releases

Deborah Kilpatrick Joins Sonder Capital as its Newest Venture Partner

PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock

PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock

PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024

Short Sellers

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on PROCEPT BioRobotics (NASDAQ: PRCT)

PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference

Comments

PROCEPT BioRobotics

Intérêt court

PROCEPT BioRobotics (NASDAQ:PRCT) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL